Development and distribution of amniotic tissue allografts

Amnio Technology specializes in the development and manufacture of chorion-free amniotic membrane and liquid products, primarily under the PalinGen® brand. Their innovative approach focuses on regenerative therapies aimed at addressing unmet needs in wound care and orthopedics. The company emphasizes the importance of using amniotic tissues derived from healthy donors, processed under strict guidelines to ensure safety and efficacy. Their proprietary Advantec© manufacturing process excludes the chorion layer, which is known to contain antigens that can trigger graft-versus-host reactions, thereby enhancing the safety profile of their products.

The product line includes various amniotic allografts, such as the PalinGen® Flow, which is currently undergoing clinical trials for its application in wound healing, particularly for diabetic foot ulcers and venous leg ulcers. These products are rich in growth factors, collagen, and other essential components that facilitate the wound healing process. Amnio Technology is committed to maintaining high-quality standards, adhering to current good tissue practices (cGTP), and ensuring compliance with FDA regulations. Their facilities are both FDA registered and accredited by the American Association of Tissue Banks (AATB), underscoring their dedication to quality and safety in regenerative medicine.

United States

Amnio Technology is an industry leader in the development and manufacture of amnion-derived technologies. Amnio Technology manufactures high-quality, amnion-derived technologies for clinical use.

Amnio Technology

Company Details